Stock 301258 SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Suzhou Fushilai Pharmaceutical Co., Ltd.

Equities

301258

CNE1000058W2

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 21/05/2024 BST 		5-day change 1st Jan Change
34.18 CNY -1.75% Intraday chart for Suzhou Fushilai Pharmaceutical Co., Ltd. +0.74% +5.89%
04-22 Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-01 Tranche Update on Suzhou Fushilai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Suzhou Fushilai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for 2022, Payable on 08 June 2023
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Certain A Shares of Suzhou Fushilai Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-MAR-2023.
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Final Announces Cash Dividend on A Shares for 2021, Payable on June 8, 2022
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Proposes Profit Distribution for 2021
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. has completed an IPO in the amount of CNY 1.107036 billion.
CI
Suzhou Fushilai Pharmaceutical Co., Ltd. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301258 Stock
  4. News Suzhou Fushilai Pharmaceutical Co., Ltd.
  5. Highlights